Clinical Trials · NCT04639414
Combined Active Treatment in Type 2 Diabetes with NASH
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- German Diabetes Center
- Enrollment
- 192
- Start date
- Mar 2021
- Locations
- 26 sites, Austria, Germany
- Primary endpoint
- Histological resolution of NASH without worsening of fibrosis